Page last updated: 2024-08-16

tetrahydropalmatine and Leukemia

tetrahydropalmatine has been researched along with Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, J; Chen, D; Chen, L; Du, X; Fan, Z; Li, K; Li, S; Lin, L; Liu, X; Lu, Y; Ma, J; Pei, R; Sha, K; Shi, X; Tang, S; Wu, J; Ye, P; Zhang, B; Zhang, P; Zhuang, X	1

Other Studies

1 other study(ies) available for tetrahydropalmatine and Leukemia

Article	Year
L-Tetrahydropalmatine Induces Apoptosis in EU-4 Leukemia Cells by Down-Regulating X-Linked Inhibitor of Apoptosis Protein and Increases the Sensitivity Towards Doxorubicin. Current molecular medicine, 2017, Volume: 17, Issue:3 Topics: Apoptosis; Berberine Alkaloids; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein	2017

Article

Year

L-Tetrahydropalmatine Induces Apoptosis in EU-4 Leukemia Cells by Down-Regulating X-Linked Inhibitor of Apoptosis Protein and Increases the Sensitivity Towards Doxorubicin.

Current molecular medicine, 2017, Volume: 17, Issue:3

Topics: Apoptosis; Berberine Alkaloids; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein

2017